Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token instead of funding its own drug
Enlivex pledged commercially reasonable efforts to hold the shareholder vote within 60 days, while the second $400 million remains optional. The post Biotech company asks shareholders to dilute stock by 951% to hoard illiquid crypto token i
Comments 0
Log in to join the conversation.
No comments yet. Be the first to share your thoughts!